Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Crowd-sourcing approach assesses current methods for improved automated detection and boundary mapping of colorectal cancer precursors

A computer vision challenge was set to objectively quantify the generalisability of polyp detection and mapping algorithms, and challenge participants to innovate novel methods.

First patient recruited to MILI trial

Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome has opened to recruitment

Challenges for colorectal cancer risk stratification in people with IBD using histology

A team of pathologists were unable to validate a histology-based assessment of cancer risk in people with inflammatory bowel disease (IBD).

Oxford Centre for Early Cancer Detection Symposium 2023 – a recap

On Tuesday 5th December, the Oxford early cancer detection community gathered at the Mathematical Institute in Oxford to hear some highlights from OxCODE’s research in the past year and to discuss ideas for future projects.

Oxford Cancer Precision Prevention Symposium – a recap

To celebrate the launch of the UK’s first CRUK clinical trials unit dedicated to cancer precision prevention in Oxford, we held a research symposium that highlighted the spectra of Cancer Precision Prevention clinical programmes across the UK.

University of Oxford Awarded £3 Million to Establish HealthTech Research Centre

The Nuffield Department of Primary Care Health Sciences wins an NIHR award for a new HealthTech Research Centre (HRC) to explore innovative Health Technology to enhance community and primary care.

OxCODE researchers at the Early Detection of Cancer Conference 2023

Oxford’s early detection research was featured at this annual event.

First private specialised haematology clinic and laboratory in sub-Saharan Africa launched

SerenOx Africa, led by Professor Anna Schuh, aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility also aims to provide early cancer detection for high-risk patients.

Collaboration announced to develop the use of AI to evaluate Barrett’s oesophagus

An agreement between Satisfai Health Inc and the University of Oxford will progress the automated assessment of Barrett’s oesophagus with the aim of determining patients most at risk of developing oesophageal cancer.

OxCODE travel awards 2023

Congratulations to James Chettle, Masato Inoue and Eoghan Mulholland who have been awarded OxCODE funds to attend this year’s Early Detection of Cancer conference in London.

MILI trial: the start of precision cancer prevention

Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome will also shed light on the mechanisms of cancer development in the general population

Disentangling a long-standing link between inflammation and cancer progression

A study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.

OxCODE funding scheme awards 2023

Congratulations to James McCullagh, Monica Olcina, Bethan Psaila, and their collaborators who have been awarded funding in the fourth round of the OxCODE Funding Scheme.

Model to predict 10-year risk of breast cancer

A team of researchers led by Professor Julia Hippisley-Cox have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.

Double funding success to improve detection and risk classification of myeloproliferative neoplasms (MPNs)

Blood Cancer UK and Cancer Research UK recognise the need and impact of artificial intelligence approaches developed by Professor Daniel Royston and Professor Jens Rittscher for early detection and assessment of these blood cancers.

Identification of a molecular signature that correlates with patient prognosis in SETD2-mutated cancers

In a pan-cancer analysis spanning 24 different cancer types, researchers shed light on the relationship between SETD2, DNA methylation and cancer development.

New tool to predict people’s risks of getting oesophageal cancer

A new study from Professor Julia Hippisley-Cox and colleagues offers hope for the earlier detection of oesophageal cancer

NIHR to fund new Policy Research Unit on Cancer Awareness, Screening, and Early Diagnosis

The National Institute for Health and Care Research (NIHR) has announced a major investment in its Policy Research Units (PRUs). Researchers in the Nuffield Department of Primary Care Health Sciences at Oxford will play a key role in a new Unit focusing on the early detection of cancer.

Oxford to launch UK’s first trials unit dedicated to conducting precision prevention and early detection studies

Oxford researchers have been given a £1 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.

Professor David Hunter appointed as a Companion of the Order of Australia

David Hunter, Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health and OxCODE Associate Director, has been appointed as a Companion of the Order of Australia in the Australian King’s Birthday Honours List.

Load More